Home » Topics » BioWorld

BioWorld
RSS

UNIVAX HAS A FULL PRODUCT PIPELINE

Sep. 16, 1991

TREDEGAR INCREASES INVESTMENT IN CTA

Sep. 16, 1991

BAXTER ASKS COURT TO DISMISS LITIGATION

Sep. 16, 1991

IVAX PLANS TO ACQUIRE NOVEN PHARMACEUTICALS

Sep. 16, 1991

APPOINTMENTS AND ADVANCEMENTS

Sep. 16, 1991

ADVANCED CF TESTING SERVICE

Sep. 13, 1991

ALLIANCE FILES FOR 2 MILLION-SHARE OFFERING

Sep. 13, 1991

DIAGNOSTIC TO COMPLETE ACQUISITION

Sep. 13, 1991

SYNTHECELL 1st CLOSING RAISES $1 MILLION

Sep. 13, 1991

RIBI'S SELECTIVE IMMUNE STIMULANT

Sep. 13, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...